These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16267793)

  • 1. [New insights in the pathogenesis of secondary hyperparathyroidism].
    Cozzolino M; Butti A; Chiarelli G; Rocca-Rey L; Bellasi A; Galassi A; Gallieni M; Brancaccio D
    G Ital Nefrol; 2005; 22(4):329-36. PubMed ID: 16267793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of parathyroid hyperplasia in renal failure.
    Cozzolino M; Brancaccio D; Gallieni M; Galassi A; Slatopolsky E; Dusso A
    J Nephrol; 2005; 18(1):5-8. PubMed ID: 15772917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of phosphorus in the pathogenesis of secondary hyperparathyroidism.
    Slatopolsky E; Brown A; Dusso A
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S54-7. PubMed ID: 11158862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure.
    Denda M; Finch J; Slatopolsky E
    Am J Kidney Dis; 1996 Oct; 28(4):596-602. PubMed ID: 8840952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of the parathyroid gland in patients with end-stage renal disease.
    Albertucci M; Zielinski CM; Rothberg M; Sterpetti A; Klingman R; Ronk JF
    Surg Gynecol Obstet; 1988 Jul; 167(1):49-52. PubMed ID: 3381185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of refractory secondary hyperparathyroidism.
    Rodriguez M; Canalejo A; Garfia B; Aguilera E; Almaden Y
    Kidney Int Suppl; 2002 May; (80):155-60. PubMed ID: 11982830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics.
    Goodman WG; Quarles LD
    Kidney Int; 2008 Aug; 74(3):276-88. PubMed ID: 17568787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid growth and suppression in renal failure.
    Lewin E; Huan J; Olgaard K
    Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure.
    Dusso A; Cozzolino M; Lu Y; Sato T; Slatopolsky E
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):507-11. PubMed ID: 15225829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of secondary hyperparathyroidism.
    Silver J; Kilav R; Naveh-Many T
    Am J Physiol Renal Physiol; 2002 Sep; 283(3):F367-76. PubMed ID: 12167586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperparathyroidism and experimental chronic renal failure.
    Boquist L; Bergdahl L; Andersson L
    Urol Res; 1973 May; 1(2):43-9. PubMed ID: 4775661
    [No Abstract]   [Full Text] [Related]  

  • 13. A correlation between decreased parathyroid α-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients.
    Yan J; Jingbo C; Wang D; Xie S; Yuan L; Zhong X; Hao L
    Int Urol Nephrol; 2015 Apr; 47(4):701-6. PubMed ID: 25749987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice.
    Arcidiacono MV; Yang J; Fernandez E; Dusso A
    Nephrol Dial Transplant; 2015 Mar; 30(3):434-40. PubMed ID: 25324357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth.
    Dusso AS; Pavlopoulos T; Naumovich L; Lu Y; Finch J; Brown AJ; Morrissey J; Slatopolsky E
    Kidney Int; 2001 Mar; 59(3):855-65. PubMed ID: 11231340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid pathology in hyperparathyroidism secondary to chronic renal failure.
    Malmaeus J; Grimelius L; Johansson H; Akerström G; Ljunghall S
    Scand J Urol Nephrol; 1984; 18(2):157-66. PubMed ID: 6379860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of parathyroid function in chronic kidney disease (CKD).
    Fukagawa M; Nakanishi S; Fujii H; Hamada Y; Abe T
    Clin Exp Nephrol; 2006 Sep; 10(3):175-9. PubMed ID: 17009074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid morphology in suppressible and nonsuppressible renal hyperparathyroidism.
    Black WC; Slatopolsky E; Elkan I; Hoffsten P
    Lab Invest; 1970 Nov; 23(5):497-509. PubMed ID: 5483883
    [No Abstract]   [Full Text] [Related]  

  • 19. Regression of parathyroid gland swelling by treatment with cinacalcet.
    Terawaki H; Nakano H; Takeguchi F; Hasegawa T; Nakayama M; Okazaki M; Hosoya T
    Nephrol Dial Transplant; 2009 Feb; 24(2):690-1; author reply 691-2. PubMed ID: 18987257
    [No Abstract]   [Full Text] [Related]  

  • 20. Weight characteristics of the parathyroid glands in renal hyperparathyroidism.
    Debruyne F; Ostyn F; Delaere P
    Head Neck; 2000 Aug; 22(5):509-12. PubMed ID: 10897112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.